BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  PDL BioPharma Announces Third Quarter 2017 Financial Results

  Total revenues of $62.7M and $252.0 million for the three and nine months ended September 30, 2017, respectively.

  November 2, 2017

   · 

  25 min read
• Business

  Juniper Pharmaceuticals Reports Third Quarter 2017 Financial and Operating Results

  Cash and cash equivalents were $22.1M at September 30, 2017, an increase of 3% from June 30, 2017.

  November 2, 2017

   · 

  14 min read
• Business

  Aratana Therapeutics Reports Third Quarter 2017 Financial Results

  Aratana reported total net revenues of $6.2 M and a net loss of $8.9M or $0.21 diluted loss per share.

  November 2, 2017

   · 

  23 min read
• Business

  Cryoport Revenue Up 52%; Driven by BioPharma

  CryoPort today announced financial results for the three- and nine-month periods ended September 30, 2017.

  November 2, 2017

   · 

  22 min read
• Business

  CONMED Corporation Announces Third Quarter 2017 Financial Results

  For the quarter ended September 30, 2017, reported net income totaled $7.2 million, compared to reported net income of $7.3 million a year ago.

  November 2, 2017

   · 

  16 min read
• 

  Business

  Biogen Poaches Merck Exec to Lead New Marketing Team

  Mr. Guindo brings 27 years of experience in the global pharma industry and has held several leadership positions at Merck.

  November 2, 2017

   · 

  4 min read
• Business

  Evonik and Lilly Renew Long-Term Supply Agreement

  Evonik Industries and Eli Lilly and Company (Lilly) today announced the renewal of a long-term agreement under which Evonik will supply active pharmaceutical ingredients (APIs) and intermediates for use in key Lilly human and veterinary drug products.

  November 2, 2017

   · 

  3 min read
• MTPConnect Opens Call For $5M Biomedtech Horizons Program, Supporting High-Potential Health Breakthroughs

  The BioMedTech Horizons program will provide $5M in 2017-18 to help Australia move more cutting-edge ideas and breakthrough discoveries towards proof-of-concept and commercialisation.

  November 2, 2017

   · 

  3 min read
• Topas Therapeutics Extends Its Series A to EUR 18 Million (USD 21 Million) With Boehringer Ingelheim Venture Fund

  BIVF will provide Topas with EUR 4 million (USD 5 million) to accelerate the Company’s preparation and execution of clinical trials for autoimmune programs derived from its platform.

  November 2, 2017

   · 

  3 min read
• MorphoSys Announces Presentation of Clinical Data on Proprietary Blood Cancer Compound MOR208 at Upcoming ASH Annual Meeting 2017

  MorphoSys announced the upcoming presentation of data on the Company’s proprietary investigational hemato-oncological program MOR208 at the 59th American Society of Hematology (ASH) Annual Meeting, being held December 9-12, 2017 in Atlanta, Georgia/USA.

  November 2, 2017

   · 

  4 min read